Borealis Biosciences raised $150 million in Series A financing led by Versant Ventures and Novartis to develop next-generation RNA therapeutics for kidney diseases.
Amount Raised
$150 Million
Round Type
Series A
VancouverBiotechnologyHealth CareTherapeuticsInvestors
Description
Borealis Biosciences emerged from stealth today with $150 million in combined Series A financing from Versant Ventures and Novartis AG. The funding will support the company's mission to address major unmet needs for patients with kidney diseases through RNA therapeutics.
Quick answer
Borealis Biosciences raised $150 Million in a Series A round, dated August 22, 2024. Investors: Novartis AG and Versant Ventures. Borealis Biosciences is based in Vancouver, British Columbia, Canada.
- How much did Borealis Biosciences raise?
- Borealis Biosciences raised $150 Million in a Series A round on August 22, 2024.
- Who invested in Borealis Biosciences?
- Novartis AG and Versant Ventures are named as investors in this round.
- What does Borealis Biosciences do?
- Borealis Biosciences was founded on the premise that a convergence of scientific and translational breakthroughs is enabling the field of RNA medicines to treat kidney diseases and beyond.
- Where is Borealis Biosciences based and how big is it?
- Borealis Biosciences is based in Vancouver, British Columbia, Canada. Fundz records about 4,193 employees.
- Who are the decision-makers at Borealis Biosciences?
- Fundz holds 2 contacts at Borealis Biosciences. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Borealis Biosciences that raised within 45 days of this round, from Fundz verified event records.
- ProEncia Biotechnology raised $1.5M (Pre-Seed) on October 4, 2024.
- Xeptiva raised $2.5M (Seed) on October 2, 2024.
- Aktis Oncology raised $175M (Series B) on September 30, 2024.
- CERo Therapeutics Holdings raised $1.3M (Seed) on September 26, 2024.
- Alpha Cognition raised $4.5M (Seed) on September 24, 2024.
- Ahammune Biosciences raised $5M (Series A) on September 24, 2024.
Who to call at Borealis Biosciences, and when
A new round usually means Borealis Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Borealis Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Borealis Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Borealis Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Borealis Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansBorealis Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.